APTOSE     Print Page | Close Window

SEC Filings

APTOSE BIOSCIENCES INC. filed this Form 6-K on 11/01/2017
Entire Document


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

      Aptose Biosciences Inc.    
Date: November 1, 2017     /s/ Gregory K. Chow    
  Gregory K. Chow
  Senior Vice President and Chief Financial Officer